Фильтр
Лекарственные препараты в России: инвестиции, проекты, холдинги
Фармацевтический рынок в России активно увеличивается со 2 квартала текущего года.
Это обуславливается тем, что июне была подписана и утверждена правительством стратегия развития фарм. промышленности до 2030 года. Согласно базовому сценарию утвержденной стратегии, доля лекарств российского производства в общем объёме потребления вырастет с 61,8 до 66,6%, а объём экспорта лекарственных препаратов должен существенно вырасти.
В настоящее время отечественными фармацевтическими предприятиями реализуется более 140 проектов по модернизации и созданию новых производственных мощностей с планируемым объемом инвестиций, превышающим 308 млрд. рублей. Наибольший объем инвестиций направлен на организацию производства фармацевтических субстанций.
(Данные обновляются)
Подотрасли:
Лекарственные препараты - 600 (······)
Регионы:
Санкт-Петербург - 64 (······), Калужская область - 30 (······), Московская область - 79 (······), Москва - 37 (······), Кировская область - 17 (······), Иркутская область - 9 (······), Владимирская область - 8 (······), Брянская область - 2 (······), Татарстан - 9 (······), Новосибирская область - 19 (······), Белгородская область - 21 (······), Рязанская область - 11 (······), Ярославская область - 14 (······), Мордовия - 14 (······), Ставропольский край - 7 (······), Чеченская республика - 5 (······), Тюменская область - 8 (······), Ленинградская область - 8 (······), Курская область - 14 (······), Курганская область - 9 (······), Мурманская область - 1 (······), Амурская область - 1 (······), Нижегородская область - 2 (······), Тульская область - 9 (······), Башкортостан - 7 (······), Приморский край - 3 (······), Калининградская область - 4 (······), Орловская область - 5 (······), Липецкая область - 4 (······), Алтайский край - 2 (······), Воронежская область - 1 (······), Пермский край - 9 (······), Псковская область - 2 (······), Свердловская область - 6 (······), Томская область - 7 (······), Самарская область - 5 (······), Новгородская область - 2 (······), Смоленская область - 3 (······), Бурятия - 1 (······), Ульяновская область - 2 (······), Краснодарский край - 4 (······), Челябинская область - 2 (······), Северная Осетия - Алания - 2 (······), Алтай - 1 (······), Кемеровская область - 4 (······), Тверская область - 2 (······), Саха/Якутия - 2 (······), Ростовская область - 3 (······), Марий Эл - 2 (······), Крым - 1 (······), Архангельская область - 1 (······), Костромская область - 2 (······), Саратовская область - 3 (······), Астраханская область - 2 (······), Удмуртская республика - 1 (······), Красноярский край - 2 (······), Ингушетия - 1 (······), Хабаровский край - 1 (······), Тамбовская область - 1 (······), Карелия - 1 (······) Показать все...
Стадии:
Введен в эксплуатацию - 300 (······), Отменен - 92 (······), Предпроектные проработки - 52 (······), Приостановлен - 39 (······), Строительство - 42 (······), Планирование - 25 (······), Проектирование - 20 (······), Подготовка к строительству - 7 (······), Модернизация - 23 (······)
Другие страны:
Беларусь - 18 (······), Казахстан - 29 (······), Узбекистан - 16 (······), Азербайджан - 5 (······), Кыргызстан - 4 (······), Сингапур - 2 (······), Таджикистан - 2 (······), Южная Корея - 1 (······), Венесуэла - 1 (······), Бахрейн - 1 (······), Канада - 2 (······), Дания - 2 (······), Австралия - 1 (······), Франция - 2 (······), Эстония - 1 (······), Германия - 1 (······), США - 3 (······), Бельгия - 1 (······), Ирландия - 1 (······), Швейцария - 1 (······), Украина - 4 (······), Алжир - 1 (······), Аргентина - 1 (······), Латвия - 1 (······) Показать все...
Новости отрасли
Головная структура одного из крупнейших отечественных фармпроизводителей и дистрибьюторов "Р-Фарм Холдинг" передала 99% своих долей в "Альбиогене" фирме "А-ген". Компания специализируется на дистрибуции оборудования для генетических исследований в Россию, в основном Illumina. Та в 2023 году сообщила, что из-за санкций и экспортных ограничений больше не может поставлять продукцию в Россию.
Комментарий ПКР: Компания "Альбиоген" выведена из контура холдинга "Р-Фарм".
········ ·············· ········ ········ ················ ················ ···· ························································.·············································· ························ ···· ························································.············································································ ·········· ···················· ·········· ·········· ·· ···· ························································.························································ ······················ ······ ······················ ·················· ······························ ·· ···· ························································.······································-·························· ·················· ···························· ······ ········ ········ ·· ············ ·············· ···· ························································.·································································· ·········· ········ ···················· ·························· ···················· ···· ························································.················································································ ···························· ········ ···· ························································.························································ ···················· ·················· ························································.························································ ···················· ···················· ·· ············ ················ ···· ························································.············································································
················ ·································· ························································.·········································································· ·············· ········ ·········· ·························· ············ ······ ························································.·········································································· ······ ······················ ·· ···· ················ ·· ·············· ·········· ······················ ········································ ················ ···················································· ········ ······ ························································.·········································································· ················ ·· ·············· ················ ···· ························································.··································································································
········ ················-··················-·················· ························································.···························································································· ·············· ···················· ·········· ········ ·········· ························ ···· ························································.······································································ ·· ························ ·················· ·············· ················ ·············· ·············· ········ ·· ················ ············ ·········· ·········· ················ ·· ·············· ···· ·············· ·· ·············· ········ ········ ······················ ·············· ···· ··········-···· ···························· ················ ·················································· ········ ······ ························································.···································································· ················ ·· ············ ················ ···· ························································.····················································································································
·································· ·············· ···· ························································.······································-···························· ······················ ·············· ·· ···· ·············· ·············· ······················ ·············· ········ ·········· ················ ·········· ······························ ················ ······················ ······ ······································ ············································ ···························· ········ ······················ ···················· ···· ························································.······································-···························· ························ ·· ········ ·················· ················ ········ ······ ················ ································
········ ···················· ················ ·········· ·············· ···· ························································.·················································· ······························ ······························································ ······ ······················ ························ ················ ················ ················ ···· ································ ·············· ·· ·········· ······ ······ ···················· ···························· ········ ············ ·········· ·············· ···· ························································.····························································································
································ ·············· ···· ························································.·································································· ············ ············ ···· ·············· ························ ············ ·········· ···················· ················ ········ ···· ························································.·············································································· ···· ············ ········ ················ ················ ·············· ········ ·················· ···· ························································.············································································ ············ ···· ·········· ············ ················ ········ ·· ············ ·········· ···· ························································.····································-········································ ·· ················ ············ ············ ·············· ···················· ················ ·· ······································ ···························· ········ ···· ························································.············································································ ················ ·· ············ ················ ···· ························································.·································································· ·· ················ ································
Топ крупнейших групп проектов в отрасли "Лекарственные препараты"
Топ-25 крупнейших проектов в отрасли "Лекарственные препараты"
Инвестиции в проекты по годам
в отрасли "Лекарственные препараты"
(Данные обновляются)
Нет данных с учетом выбранных параметров
Топ проектов 2023 - 2034
Ввод в эксплуатацию проектов по годам
в отрасли "Лекарственные препараты"
(Данные обновляются)
Нет данных с учетом выбранных параметров
Топ проектов 2023 - 2034
Холдинги - Инвесторы проектов
в отрасли "Лекарственные препараты"
(Данные обновляются)
Нет данных с учетом выбранных параметров
Динамика выручки холдингов инвесторов отрасли
в отрасли "Лекарственные препараты"
(Данные обновляются)
Нет данных по заданным фильтрам
Холдинги - Инвесторы проектов
(Данные обновляются)
Нет данных с учетом выбранных параметров
Холдинги - Генеральные проектировщики
в отрасли "Лекарственные препараты"
(Данные обновляются)
Нет данных с учетом выбранных параметров
Холдинги - Генеральные проектировщики
(Данные обновляются)
Нет данных с учетом выбранных параметров
Холдинги - Генеральные подрядчики
в отрасли "Лекарственные препараты"
(Данные обновляются)
Нет данных с учетом выбранных параметров
Холдинги - Генеральные подрядчики
(Данные обновляются)
Нет данных с учетом выбранных параметров
Динамика добавления новых проектов
в отрасли "Лекарственные препараты"
(Данные обновляются)
Нет данных с учетом выбранных параметров
Реализованные проекты по холдингам
в отрасли "Лекарственные препараты"
(Данные обновляются)
Нет данных с учетом выбранных параметров
Проекты на активной стадии (без приостановленных)
в отрасли "Лекарственные препараты"
(Данные обновляются)
Нет данных с учетом выбранных параметров
Динамика ввода в эксплуатацию
в отрасли "Лекарственные препараты"
(Данные обновляются)
Нет данных с учетом выбранных параметров
Динамика приостановки проектов
в отрасли "Лекарственные препараты"
(Данные обновляются)
Нет данных с учетом выбранных параметров
Динамика отмены проектов
в отрасли "Лекарственные препараты"
(Данные обновляются)
Нет данных с учетом выбранных параметров
Структура инвестиций по видам строительства
в отрасли "Лекарственные препараты"
(Данные обновляются)
Нет данных с учетом выбранных параметров
Структура инвестиций по подотраслям
в отрасли "Лекарственные препараты"
(Данные обновляются)
Нет данных с учетом выбранных параметров
Структура инвестиций по отраслям
в отрасли "Лекарственные препараты"
(Данные обновляются)
Нет данных с учетом выбранных параметров
Динамика выручки холдингов инвесторов отрасли в отрасли "Лекарственные препараты"
Планирование
Предпроект
Проектирование 
Подг. к строительству 
Строительство 
Введен в эксплуатацию 
Модернизация 
Приостановлен 
Россия 
Другие страны
Структура инвестиций по стадиям
в отрасли "Лекарственные препараты"
(Данные обновляются)
Нет данных с учетом выбранных параметров
Структура инвестиций по регионам РФ
в отрасли "Лекарственные препараты"
(Данные обновляются)
Нет данных с учетом выбранных параметров
Структура инвестиций по федеральным округам РФ
в отрасли "Лекарственные препараты"
(Данные обновляются)
Нет данных с учетом выбранных параметров
Структура инвестиций по видам собственности
в отрасли "Лекарственные препараты"
(Данные обновляются)
Нет данных с учетом выбранных параметров
Структура инвестиций по видам собственности
в отрасли "Лекарственные препараты"
(Данные обновляются)
Нет данных с учетом выбранных параметров
Динамика выручки холдингов инвесторов отрасли
в отрасли "Лекарственные препараты"
(Данные обновляются)
Нет данных с учетом выбранных параметров
Структура инвестиций в иностранной собственности без российских бенефициаров
в отрасли "Лекарственные препараты"
(Данные обновляются)
Нет данных с учетом выбранных параметров
Структура инвестиций в иностранной собственности
в отрасли "Лекарственные препараты"
(Данные обновляются)
Нет данных с учетом выбранных параметров
Российские инвестиции в другие страны
в отрасли "Лекарственные препараты"
(Данные обновляются)
Нет данных с учетом выбранных параметров
Российские генподрядчики в других странах
в отрасли "Лекарственные препараты"
(Данные обновляются)
Нет данных с учетом выбранных параметров
Российские генпроектировщики в других странах
в отрасли "Лекарственные препараты"
(Данные обновляются)
Нет данных с учетом выбранных параметров
